AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-2.15%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.36B
AUM Growth
+$1.36B
Cap. Flow
-$23.4M
Cap. Flow %
-1.72%
Top 10 Hldgs %
86.25%
Holding
89
New
7
Increased
16
Reduced
1
Closed
9

Top Buys

1
AMZN icon
Amazon
AMZN
$16.2M
2
INCY icon
Incyte
INCY
$15.8M
3
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
$12.8M
4
IONS icon
Ionis Pharmaceuticals
IONS
$12.2M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$6.2M

Top Sells

1
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$69.5M
2
AMGN icon
Amgen
AMGN
$18.5M
3
DG icon
Dollar General
DG
$13.9M
4
MJN
Mead Johnson Nutrition Company
MJN
$12.5M
5
BRFS icon
BRF SA
BRFS
$8.93M

Sector Composition

1 Consumer Discretionary 45.67%
2 Healthcare 44.28%
3 Financials 2.04%
4 Industrials 0.98%
5 Technology 0.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5M 0.2% 250,000 – –
XOMA icon
27
Xoma
XOMA
$392M
$4.59M 0.19% 1,000,000 – –
RL icon
28
Ralph Lauren
RL
$18B
$4.02M 0.16% 25,000 -25,000 -50% -$4.02M
CSLT
29
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.8M 0.15% 250,000 +150,000 +150% +$2.28M
ONIT
30
Onity Group Inc.
ONIT
$333M
$3.71M 0.15% +100,000 New +$3.71M
IRWD icon
31
Ironwood Pharmaceuticals
IRWD
$214M
$3.33M 0.13% 216,879 – –
RDN icon
32
Radian Group
RDN
$4.72B
$2.96M 0.12% +200,000 New +$2.96M
RXDX
33
DELISTED
Ignyta, Inc.
RXDX
$2.73M 0.11% 300,000 – –
STML
34
DELISTED
Stemline Therapeutics, Inc.
STML
$2.49M 0.1% 170,000 +15,000 +10% +$220K
SPHS
35
DELISTED
Sophiris Bio, Inc.
SPHS
$2.24M 0.09% 1,000,000 – –
SFXE
36
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$2.03M 0.08% +250,000 New +$2.03M
AMBI
37
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
$1.73M 0.07% 250,000 – –
CCXI
38
DELISTED
ChemoCentryx, Inc.
CCXI
$1.61M 0.07% 275,000 – –
BAC icon
39
Bank of America
BAC
$376B
$1.54M 0.06% +100,000 New +$1.54M
AGEN
40
Agenus
AGEN
$133M
$1.32M 0.05% 410,130 – –
AMGN icon
41
Amgen
AMGN
$155B
– – -150,000 Closed -$18.5M
AMRN
42
Amarin Corp
AMRN
$311M
– – 0 – –
BIIB icon
43
Biogen
BIIB
$19.4B
– – 0 – –
BMY icon
44
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
BRFS icon
45
BRF SA
BRFS
$6.12B
– – -446,900 Closed -$8.93M
CL icon
46
Colgate-Palmolive
CL
$67.9B
– – 0 – –
COF icon
47
Capital One
COF
$145B
– – 0 – –
CPAC
48
Cementos Pacasmayo
CPAC
$581M
– – -256,975 Closed -$2.25M
CTSH icon
49
Cognizant
CTSH
$35.3B
– – 0 – –
DG icon
50
Dollar General
DG
$23.9B
– – -250,000 Closed -$13.9M
1
2
3 4